Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Therapeutic Advances in Hematology
|
April 5, 2013
The role of intravenous iron in the treatment of anemia in cancer patients
H Tilman Steinmetz
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS
|
April 12, 2023
[Anemia: Diagnostics and Therapy]
Hans Tesch, Hans Tilman Steinmetz, Hartmut Link
Oncology Research and Treatment
|
September 16, 2021
Effectiveness of Long-Term Treatment of Multiple Myeloma in Regular Care: Comparison of a Longitudinal and a Cross-Sectional Analysis Approach
Tilman Steinmetz, Angela Ernst, Martin Hellmich, et al.
Annals of Hematology
|
August 22, 2024
MDS patient registries - achievements and challenges
Tilman Steinmetz, Uwe Totzke, Annika Kasprzak, et al.
Advances in Therapy
|
June 21, 2025
Treatment Patterns, Goals, and Decision-Making Criteria for Second- and Third-Line Therapies for Multiple Myeloma in Germany
H Tilman Steinmetz, Franziska Ertel, Beate Brinkmann, et al.
Anemia
|
March 12, 2016
Antianemic Treatment of Cancer Patients in German Routine Practice: Data from a Prospective Cohort Study-The Tumor Anemia Registry
Tilman Steinmetz, Jan Schröder, Margarete Plath, et al.
Advances in Therapy
|
January 16, 2022
Management of Patients with Relapsed and/or Refractory Multiple Myeloma Treated with Novel Combination Therapies in Routine Clinical Practice in Germany
H Tilman Steinmetz, Moushmi Singh, Joseph Milce, et al.
Oncology Research and Treatment
|
July 23, 2020
Patient Characteristics and Outcomes of Relapsed/Refractory Multiple Myeloma in Patients Treated with Proteasome Inhibitors in Germany
H Tilman Steinmetz, Moushmi Singh, Andrea Lebioda, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
January 24, 2026
Effectiveness and safety of pegylated filgrastim (Pelgraz®) for the prevention of febrile neutropenia during cancer chemotherapy in all-day practice in Germany
Tilman Steinmetz, Peter Jungberg, Dagmar Guth, et al.
The Oncologist
|
July 3, 2007
Prediction of the responsiveness to treatment with erythropoiesis-stimulating factors: a prospective clinical study in patients with solid tumors
Tilman Steinmetz, Martin Hellmich, Michael Neise, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Therapeutic Advances in Hematology
|
April 5, 2013
The role of intravenous iron in the treatment of anemia in cancer patients
H Tilman Steinmetz
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS
|
April 12, 2023
[Anemia: Diagnostics and Therapy]
Hans Tesch, Hans Tilman Steinmetz, Hartmut Link
Oncology Research and Treatment
|
September 16, 2021
Effectiveness of Long-Term Treatment of Multiple Myeloma in Regular Care: Comparison of a Longitudinal and a Cross-Sectional Analysis Approach
Tilman Steinmetz, Angela Ernst, Martin Hellmich, et al.
Annals of Hematology
|
August 22, 2024
MDS patient registries - achievements and challenges
Tilman Steinmetz, Uwe Totzke, Annika Kasprzak, et al.
Advances in Therapy
|
June 21, 2025
Treatment Patterns, Goals, and Decision-Making Criteria for Second- and Third-Line Therapies for Multiple Myeloma in Germany
H Tilman Steinmetz, Franziska Ertel, Beate Brinkmann, et al.
Anemia
|
March 12, 2016
Antianemic Treatment of Cancer Patients in German Routine Practice: Data from a Prospective Cohort Study-The Tumor Anemia Registry
Tilman Steinmetz, Jan Schröder, Margarete Plath, et al.
Advances in Therapy
|
January 16, 2022
Management of Patients with Relapsed and/or Refractory Multiple Myeloma Treated with Novel Combination Therapies in Routine Clinical Practice in Germany
H Tilman Steinmetz, Moushmi Singh, Joseph Milce, et al.
Oncology Research and Treatment
|
July 23, 2020
Patient Characteristics and Outcomes of Relapsed/Refractory Multiple Myeloma in Patients Treated with Proteasome Inhibitors in Germany
H Tilman Steinmetz, Moushmi Singh, Andrea Lebioda, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
January 24, 2026
Effectiveness and safety of pegylated filgrastim (Pelgraz®) for the prevention of febrile neutropenia during cancer chemotherapy in all-day practice in Germany
Tilman Steinmetz, Peter Jungberg, Dagmar Guth, et al.
The Oncologist
|
July 3, 2007
Prediction of the responsiveness to treatment with erythropoiesis-stimulating factors: a prospective clinical study in patients with solid tumors
Tilman Steinmetz, Martin Hellmich, Michael Neise, et al.
Page
of 2